4 completed, 4 unknown, 2 recruiting, 1 withdrawn. 3 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Ischemic Optic Neuropathy: new trials by email Literature Review of Ischemic Optic Neuropathy trials Research Report on Ischemic Optic Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis Positron Emission Tomography / Magnetic Resonance Imaging - Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy | Recruiting | Copenhagen University Hospital, Rigshospitalet | 122 | 2026-01-14 | 2026-05-07 | |
| Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy. Neuroimaging, VEP - visual evoked potential, Ophthalmology examination. - Ischemic Optic Neuropathy, Optic Neuritis | Not applicable | Unknown | Medical University of Bialystok | 20 | 2020-01-01 | 2022-04-29 |
| New Non-invasive Modalities for Assessing Retinal Structure and Function LSFG-NAVI - Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion | Not applicable | Recruiting | Randy Kardon | 500 | 2019-05-06 | 2026-09-08 |
| Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy Alprostadil 20 micrograms, Placebo - Ischemic Optic Neuropathy | Phase 2 | Unknown | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 24 | 2018-06-13 | 2019-02-25 |
| ENDOTHELION Study Group: Effect of Bosentan in NAION Patients bosentan, placebo - Ischemic Optic Neuropathy | Phase 3 | Unknown | University Hospital, Grenoble | 86 | 2015-08-01 | 2022-07-07 |
| Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery VEP under TIVA, VEP under balanced anesth., Propofol - Ischemic Optic Neuropathy | Not applicable | Completed | Ohio State University | 20 | 2014-09-01 | 2017-08-01 |
| Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% Timolol maleate - Optic Neuropathy, Ischemic, Anterior Ischemic Optic Neuropathy | Phase 1 | Withdrawn | Fraser Health | 2012-06-01 | 2015-05-25 | |
| Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) No intervention given in this observational study - Anterior Ischemic Optic Neuropathy, Ischemic Optic Neuropathy | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 21283 | 2008-08-01 | 2021-02-01 | |
| Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair Problem With Vision Blindness, Intraocular Pressure | Completed | University of Manitoba | 10 | 2007-03-01 | 2014-03-31 | |
| Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup) Surgery - Ischemic Optic Neuropathy | Unknown | National Eye Institute (NEI) | 1994-10-01 | 2006-05-26 | ||
| Ischemic Optic Neuropathy Decompression Trial (IONDT) Optic Nerve Sheath Decompression Surgery - Ischemic Optic Neuropathy | Phase 3 | Completed | National Eye Institute (NEI) | 1992-10-01 | 2010-03-24 |
Optic Neuropathy, Ischemic (11) · Optic Nerve Diseases (3) · Acute zonal occult outer retinopathy (1) · Giant Cell Arteritis (1) · Hemianopsia (1) · Ischemia (1) · Optic Atrophy, Hereditary, Leber (1) · Optic Nerve Injuries (1) · Optic Neuritis (1) · Retinal Artery Occlusion (1) · Retinal Diseases (1) · Toxic Optic Neuropathy (1)
Cardiovascular Diseases (11) · Cranial Nerve Diseases (11) · Eye Diseases (11) · Nervous System Diseases (11) · Vascular Diseases (11) · Optic Nerve Diseases (8) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Arterial Occlusive Diseases (1) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Blindness (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Bosentan (1) · Desflurane (1) · Magnetic Resonance Imaging (1) · Neuroimaging (1) · Positron-Emission Tomography (1) · Propofol (1) · Surgical Procedures, Operative (1) · Timolol (1) · Tomography, Optical Coherence (1)
National Eye Institute (NEI) (2) · Copenhagen University Hospital, Rigshospitalet (1) · Fraser Health (1) · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1) · Medical University of Bialystok (1) · Ohio State University (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Randy Kardon (1) · University Hospital, Grenoble (1) · University of Manitoba (1)
United States (3) · Canada (2) · Denmark (1) · France (1) · Poland (1) · Spain (1)
Amit Chopra, M.D. (1) · Martin A SuttonBrown, MD (1) · Randy H Kardon, MD, PhD (1) · Sergio D Bergese, MD (1)
2014 (1)